Patients With Clinically Detectable And Resectable Stage Iii Iv Melanoma clinical trials

Explore recruiting patients with clinically detectable and resectable stage iii iv melanoma clinical trials.

Recruiting patients with clinically detectable and resectable stage iii iv melanoma studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Patients With Clinically Detectable And Resectable Stage Iii Iv Melanoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

NeoLIPA: A multi center phase II open label study of neoadjuvant LTX-315 in combination with pembrolizumab in patients with clinically detectable and resectable stage III-IV melanoma

Norway

Therapeutic exploratory (Phase II) EU CTIS Study details

Patients With Clinically Detectable And Resectable Stage Iii Iv Melanoma trials by city

Patients With Clinically Detectable And Resectable Stage Iii Iv Melanoma in Toronto Patients With Clinically Detectable And Resectable Stage Iii Iv Melanoma in Vancouver Patients With Clinically Detectable And Resectable Stage Iii Iv Melanoma in Montreal Patients With Clinically Detectable And Resectable Stage Iii Iv Melanoma in Calgary Patients With Clinically Detectable And Resectable Stage Iii Iv Melanoma in Edmonton Patients With Clinically Detectable And Resectable Stage Iii Iv Melanoma in Ottawa Patients With Clinically Detectable And Resectable Stage Iii Iv Melanoma in Winnipeg Patients With Clinically Detectable And Resectable Stage Iii Iv Melanoma in Quebec City Patients With Clinically Detectable And Resectable Stage Iii Iv Melanoma in Hamilton Patients With Clinically Detectable And Resectable Stage Iii Iv Melanoma in Kitchener Patients With Clinically Detectable And Resectable Stage Iii Iv Melanoma in London Patients With Clinically Detectable And Resectable Stage Iii Iv Melanoma in Halifax Patients With Clinically Detectable And Resectable Stage Iii Iv Melanoma in New York Patients With Clinically Detectable And Resectable Stage Iii Iv Melanoma in Los Angeles Patients With Clinically Detectable And Resectable Stage Iii Iv Melanoma in Chicago Patients With Clinically Detectable And Resectable Stage Iii Iv Melanoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease